| Literature DB >> 35721327 |
Zsuzsanna Kahán1, István Szántó2, Rita Dudás1, Zsuzsanna Kapitány3, Mária Molnár4, Zsuzsa Koncz5, Mónika Mailáth6.
Abstract
Follow-up includes ongoing contact with and health education of the patient, surveillance and control of the adverse effects of surgery, oncological therapies or radiotherapy, screening of metachronous cancers, and comprehensive (physical, psychological and social) patient rehabilitation, which may be enhanced by a healthy lifestyle. Primary attention should be paid to early detection and, when needed, curative treatment of local/regional tumour recurrences. Similarly, with the hope of curative solution, it is important to recognize the entity of a low-mass and relatively indolent recurrence or metastasis (oligometastasis); however, there is still no need to investigate distant metastases by routine diagnostic imaging or assess tumour markers. Below there is a list of possible sources of support, with respect to adjuvant hormone therapy continued during long-term care, social support resources, pivotal points and professional opportunities for physical and mental rehabilitation. Individual solutions for specific issues (breast cancer risk/genetic mutation, pregnancy) are provided by constantly widening options. Ideally, a complex breast cancer survivorship programme is practised by a specially trained expert supported by a cooperative team of oncologists, surgeons, breast radiologists, social workers, physiotherapists, psycho-oncologists and psychiatrists. The approach of follow-up should be comprehensive and holistic.Entities:
Keywords: follow-up; healthy lifestyle; physical rehabilitation; psychosocial oncology care; side-effect management; social rehabilitation
Mesh:
Year: 2022 PMID: 35721327 PMCID: PMC9200958 DOI: 10.3389/pore.2022.1610391
Source DB: PubMed Journal: Pathol Oncol Res ISSN: 1219-4956 Impact factor: 2.874
Adverse consequences of breast cancer treatments complained during follow-up.
| Treatment | Side effects developing during treatment | Side effects developing months or years after treatment |
|---|---|---|
| Surgery | Numbness, body image problems, cosmetic outcome, sexual dysfunction, restricted motion of the shoulders, pain | Lymphoedema, neuropathy, restricted motion of the shoulders, pain |
| Radiotherapy | Skin lesions, breast fibrosis, asymmetry, cosmetic issues, pain, body image disorders, sexual dysfunction, pneumonitis, lymphoedema | Soft tissue fibrosis, ischaemic heart disease, radiogenic secondary malignancy |
| Chemotherapy | Cognitive impairment (“chemo brain”), fatigue, early menopause, infertility, sexual dysfunction, hair loss, weight changes, neuropathy, cardiomyopathy | Sterility / hormone deficiency / menopause, osteoporosis / osteopenia, leukaemia / myelodysplastic syndrome, cardiomyopathy |
| Trastuzumab | Reversible heart damage | |
| Tamoxifen | Hot flushes, menstrual disorders, mood disorders, vaginal discharge/infection, elevated triglyceride levels | Stroke, endometrial cancer, thromboembolic event, osteopenia in premenopause |
| Aromatase inhibitors | Vaginal dryness, decreased libido, joint and muscle pain, increased cholesterol levels, gastrointestinal symptoms, urinary incontinence, impaired cognitive functions | Osteoporosis, risk of fracture |
Follow-up assessments during adjuvant endocrine therapy.
| Medication | Premenopause | Menopause |
|---|---|---|
| Tamoxifen | DEXA every 2–3 years Yearly gynecology checkup | Yearly gynecology checkup |
| GnRH/LHRH analogs | DEXA | — |
| Aromatase inhibitors | DEXA every two years | DEXA every two years |
GnRH, gonadotropin releasing-hormone; LHRH, luteinising hormone-releasing hormone; DEXA, Dual Energy X-ray Absorptiometry (bone density measurement).
Approximate energy expenditures for selected forms of activities.
| Category | Self care | Occupational | Sport | Physical conditioning |
|---|---|---|---|---|
| Very light MET 3 | Bathing, shaving, dish washing, dressing, writing, driving, desk work | Sitting (office) or standing (service) work, truck driving, operating a crane | Playing billiards golf, archery, boating, slow dancing | Walking at 3 km/h, stationary exercise bike with very low resistance, very light gymnastics |
| Light MET 3–5 | Window cleaning, leaf-raking, weeding, sickling, machine mowing, painting, carrying items weighing 7–15 kg | Shelving light objects, light welding, light carpentry, repairing machines, car fixing, hanging pictures, wallpapering | Dancing, golf (walking), sailing, volleyball, doubles tennis, horse riding | Walking at 4.5–6 km/h, cycling at 9–12 km/h, light gymnastics |
| Moderate MET 5–7 | Easy digging, hand grass levelling, slow stair climbing, carrying loads weighing 15–30 kg | Easy carpentry, garbage shovelling, use of pneumatic tools | Badminton, singles tennis, skiing (downhill), light backpacking, basketball, football, ice skating, galloping | Walking at 6.5–7.5 km/h, cycling 9–12 km/h, swimming (breaststroke) |
| Difficult | Wood sawing, heavy shovelling, stair climbing at limited speeds, carrying loads weighing 30–45 kg | Firing in a furnace, trench digging, pickaxing, shovelling | Canoeing, playing rugby, mountaineering, fencing | Jogging, swimming (freestyle), cycling at 18 km/h, heavy gymnastics, rowing machine workout |
| MET 7–9 | ||||
| Very difficult MET 9 | Carrying load on stairs, carrying loads over 45 kg, fast stair climbing, heavy snow shovelling | Wood cutting, hard physical work | Handball, squash, skiing (hiking), intense basketball playing | Running at > 9 km/h, cycling at > 18 km/h or uphill, rope jumping |
MET, metabolic equivalent of task.
Minimum recommended exercise for healthy individuals.
| American recommendations | European recommendations |
|---|---|
| at least 150 minutes/week of moderate intensity or 75 minutes/week of intense aerobic exercise | Minimum 30 minutes of moderate-intensity exercise 5 days a week or at least 20 minutes of vigorous exercise 3 days a week |
| Exercise should consist of units lasting at least 10 minutes | Activity can be gathered from units of at least 10 minutes |
| Further beneficial effects result from increasing workout time to 300 minutes/week for moderate-intensity or to 150 minutes/week for vigorous aerobic exercise, in adults. It is recommended to perform moderate or high intensity muscle strengthening activity for 2 or more days, involving all major muscle groups | It is recommended to perform additional muscle strengthening and endurance exercises 2–3 days a week |
Options of functional locomotory tests.
| Function, abnormality | Tool | Manual examination by a physiotherapist |
|---|---|---|
| Range of motion (ROM) | Goniometer | functional tests |
| Muscular strength | Dynamometer | Oxford scale (0–5) |
| Upper limb volume | optoelectric instrument plethysmography water displacement method Khunke’s volume formula | a state characteristic (Khunke’s formula) recorded on the basis of a series of circumferences (k1, k2…) measured every 4 cm perpendicularly to the axis of the affected limb, suitable for follow-up |
| Scarring, axillary web syndrome, AWS | visible and / or palpable cording pain restricted ROM for flexion and abduction (usually an axillary phenomenon, but elbow and wrist involvement may also occur) |
Questionnaires designed for complex examination of upper limb functions in patients with locomotor disorders.
| “The Disabilities of the Arm, Shoulder and Hand”, | To measure complex functions of the upper limb | 30 questions, of which 25 ask about functions related to lifestyle, and 5 about other symptoms (score 1–5) optional questions related to work, sports, artistic activities (4 for each category) | high score weak function |
| 10 minutes ( | |||
|
| An abbreviated version of DASH can be evaluated if there are >9 responses | 11 questions | high score poor function |
| 3 minutes | |||
| “Upper Extremity Functional Index”, | |||
| 3 to 4 minutes ( | To measure upper limb function | 20 questions (score 0–4) | high score good function |
|
| Multidimensional quality of life questionnaire | 36 questions (score 0–4) | high score good quality of life |
|
| Multidimensional quality of life questionnaire expanded with questions on 4 upper limb functions | 40 questions (score 0–4) | high score good quality of life |
| “Kwan’s Arm Problem Scale”, | Upper limb function questionnaire for cancer patients | 13 questions (score 1–5) it is also a psychometric indicator pain, stiffness, swelling, function | high score with more symptoms and poor function |
| “Subjective Perception of Post-Operative Functional Impairment of the Arm”, | To assess condition after breast cancer surgery | 15 questions swelling, pain, anaesthesia, restricted range of motion and decreased muscle strength | a high score indicates marked upper limb damage |
Common psychosocial symptoms that occur during certain stages of the disease.
| Stage of the disease | Possible psychological / psychiatric phenomena and symptoms |
|---|---|
| Secondary prevention/cancer screening | Anxiety, communication and compliance difficulties, fear of social stigmatization, health anxiety, negligence, fear caused by a positive family history, procrastinating behaviour |
| Psychosocial consequences of confirmed high genetic risk (e.g. insecurity, anxiety disorders, fear of disease) | |
| Diagnostic work-up | Establishment of a doctor-patient relationship and its difficulties; the patient is becoming “familiar” with the health care system, the patient’s early experiences are “engraved” and will be decisive; the impact of issues related to the health system on the patient. |
| Fear of “violation” of bodily integrity, fear of pain, fear of the patient role, fear of the loss of autonomy. Temporary narrowing of concentration and thought processes. Frequent intrusion into the private sphere (a matter of trust and attachment!), depersonalization, loss of security, chronic stress (long waiting times, fear of illness) | |
| Communication of diagnosis, preparing for surgical procedures, discussing the treatment | A diagnosis of cancer may often induce psychological trauma, a mental crisis. In addition to the most common fears raised when the diagnosis is communicated (fear of death, loss of autonomy, pain, treatments, etc.), anxiety and depressive disorders (e.g., PTSD), cognitive dysfunction (e.g., restricted thinking and focus of attention), topic-specific problems should be highlighted: body scheme changes, self-esteem, partnership and sexual issues. |
| When a patient first finds out the diagnosis, there may be violent emotional reactions, extreme manifestations, and complete introversion may even occur, which are natural emotional reactions to shock; however, they may require crisis intervention. | |
| Information and preparation before the (new) oncotherapy phase reduce anxiety and improve compliance. | |
| Oncotherapy (surgery, chemotherapy, radiation therapy, hormone therapy) | Increasing communication difficulties (between patients, physicians, the medical staff and the relatives of the patient) due to physical and mental stress. |
| Frustration, adjustment difficulties, mental regression, fear of death, internal / external body image disorders, depressive symptoms (due to the loss of health, but may also be biologically or drug-induced or of CNS origin), anxiety, psychosomatic symptoms, PTSD, relationship and sexual problems, psychogenic side effects. | |
| Early side effects of chemotherapy, anticipatory nausea and vomiting may lead to treatment discontinuation and prolonged aversion, reducing the possibility of re-treatment in the event of relapse. | |
| Unrealistic adherence to or rejection of treatment. | |
| Cognitive impairment after chemotherapy: impairment of concentration and integration, learning disabilities (20%–50%), mild decrease in IQ (cognitive impairment may be exacerbated by psychogenic factors). | |
| In patients with non-cerebral metastases, mild EEG abnormalities, paraesthesias occur in about 20% of cases. Changes in sexual life, family task allocation, relationship problems. | |
| Increasing financial burdens may change the patient’s economic and social status. | |
| Elevated levels of distress (sleep disturbance, restlessness, mood swings, anxiety, depressed mood, depression, fatigue syndrome), which compromise quality of life. | |
| As a result of regular or long-term hospital treatments, hospitalization, separation from the family and social isolation may develop. | |
| As a result of increased physical and mental strain, premorbid psychiatric problems may become exacerbated or decompensated; therefore, special attention should be paid to people who have been previously diagnosed or have avoided psychiatry, but are currently suffering from some form of comorbid psychiatric disorder (the importance of screening!). | |
| Any treatment type may cause anticipatory anxiety symptoms, grief reactions (due to loss of health or independence, etc.), and anticipatory bereavement. | |
| Follow-up phase/ relapse-free phase | Adaptation difficulties, persistence of conditioned psychogenic side-effects, cognitive impairment, chronic fatigue, Damocles’ syndrome, PTSD, sexual disorders, development and exacerbation of addictions; loss of security, psychosomatic symptoms, mood disorders (depression), anxiety disorders (panic disorder, hypochondria, carcinophobia), risk of suicide. |
| Relapse, palliative care | Emotional crisis, anger, anxiety, depression, fear of death, adjustment / coping difficulties. Increased guilt, emotional instability, tension, anger, overt or hidden hostility, intellectual inhibition, mental regression, depersonalization. |
| Terminal stage | Fear of death, anxiety; rejection (denial), anger, bargaining, depression, resignation. |
Algorithm for oncopsychological screening.
| Distress → short evaluation (e.g. distress thermometer) + list of problems→ | Moderate or severe distress, DT = 4 or more | → | Clinical assessment: validated scales, screening tests to measure anxiety/depression (oncologist, nurse, social worker or trained professional) in the following cases: | →Referral, | →Mental healthcare providers Psychiatry/psychology care) |
| • high risk patient | |||||
| ○ high vulnerability period | |||||
| → | Non-relieved physical symptoms (treated according to disease- specific or palliative care guidelines) | ○ distress risk factors are present- practical issues | if needed | →Social worker and counselling services | |
| • family issues | |||||
| • spiritual/religious issues | |||||
| Clinically confirmed mild distress or DT <4 | • physical problems | Primary oncology care team + available resources | →Spiritual care (pastor) | ||
| • social problems | |||||
| • emotional problems (e.g. anxiety, depression) | |||||
|
| |||||
Source: NCCN Guidelines Version 1. 2020 Distress Management, National Comprehensive Cancer Network (2020) (65).